CGI
PFE icon

CI Global Investments’s Pfizer PFE Stock Holding History

CI Global Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-701,361
Closed -$22.4M – 108
2017
Q2 		$22.4M Buy
+701,361
New +$22.1M 0.42% 45
2014
Q2 		– Sell
-830,130
Closed -$25.3M – 217
2014
Q1 		$25.3M Buy
830,130
+102,870
+14% +$3.07M 0.67% 43
2013
Q4 		$21.1M Buy
727,260
+52,700
+8% +$1.53M 0.6% 45
2013
Q3 		$18.4M Buy
674,560
+94,860
+16% +$2.58M 0.69% 51
2013
Q2 		$15.4M Buy
+579,700
New +$16M 0.7% 49

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

CI Global Investments's PFE Position: Q3 2017 in Review

CI Global Investments sold out of Pfizer (PFE) in Q3 2017, closing a stake of 701,361 shares — an estimated $22.4M sold.

CI Global Investments first reported a position in PFE in Q2 2013 and held it in 5 quarters. The position peaked at $25.3M in Q1 2014. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • CI Global Investments reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • CI Global Investments sold 701,361 Pfizer shares in Q3 2017, an estimated $22.4M.
  • CI Global Investments first reported a position in Pfizer in Q2 2013 and held it in 5 quarters.
  • CI Global Investments's Pfizer position peaked at $25.3M in Q1 2014.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on CI Global Investments's 13F filing for Q3 2017, filed 6 Nov 2017.